William John Thomas

William John Thomas is a declared insider at 2 companies; the most frequent names are Orchid Cellmark Inc and Cytogen Corp. We count 10 filings; the first trade dates from 4 April 2006 and the latest from 9 December 2011.

Purchases make up the whole of the open-market record (6 purchases, €2,144). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 3 share grants.

The median purchase comes to €320.

The newest entry dates from 13 December 2011: a transaction of €2,098, in Orchid Cellmark Inc. The most recent open-market purchase was published on 7 August 2008, 6,651 days ago. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.